Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
Cardiovasc Res
    August 2025
  1. HASTINGS MH, Zhou Q, Wu C, Shabani P, et al
    Cardiac ageing: from hallmarks to therapeutic opportunities.
    Cardiovasc Res. 2025;121:1474-1488.
    >> Share

    July 2025
  2. BOGDANOV V, Mariangelo JIE, Soltisz AM, Sakuta G, et al
    Distinct intracellular spatiotemporal expression of Calmodulin genes underlies functional diversity of Calmodulin-dependent signalling in cardiac myocytes.
    Cardiovasc Res. 2025;121:1052-1065.
    >> Share

    June 2025
  3. LI F, Du WW, Li X, Wen S, et al
    A new protein isoform encoded by human circular RNA circSLC8a1 contributes to cardiac remodelling.
    Cardiovasc Res. 2025;121:882-899.
    >> Share

  4. RAYNER JJ, Abdesselam I, Pan J, Lewis AJM, et al
    Obesity and heart failure: exploring the cardiometabolic axis.
    Cardiovasc Res. 2025 Jun 3:cvaf090. doi: 10.1093.
    >> Share

    May 2025
  5. CELIK S, Hyrefelt L, Czuba T, Li Y, et al
    Antisense-mediated regulation of exon usage in the elastic spring region of Titin modulates sarcomere function.
    Cardiovasc Res. 2025;121:629-642.
    >> Share

    April 2025
  6. MIRA HERNANDEZ J, Shen EY, Ko CY, Hourani Z, et al
    Differential sex-dependent susceptibility to diastolic dysfunction and arrhythmia in cardiomyocytes from obese diabetic heart failure with preserved ejection fraction model.
    Cardiovasc Res. 2025;121:254-266.
    >> Share

  7. WONG LL, Koh HWL, Choi H, Zou R, et al
    Combined circulating microRNA and peptide biomarkers for prognostication in heart failure.
    Cardiovasc Res. 2025 Apr 17:cvaf065. doi: 10.1093.
    >> Share

  8. JANSSEN-TELDERS C, Eringa EC, de Groot JR, de Man FS, et al
    The role of epicardial adipose tissue remodelling in heart failure with preserved ejection fraction.
    Cardiovasc Res. 2025 Apr 16:cvaf056. doi: 10.1093.
    >> Share

    March 2025
  9. DAVIDSON SM, Andreadou I, Antoniades C, Bartunek J, et al
    Opportunities and challenges for the use of human samples in translational cardiovascular research: a scientific statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on B
    Cardiovasc Res. 2025 Mar 14:cvaf023. doi: 10.1093.
    >> Share

    February 2025
  10. TIMMER LT, den Hertog E, Versteeg D, Post H, et al
    Cardiomyocyte SORBS2 expression increases in heart failure and regulates integrin interactions and extracellular matrix composition.
    Cardiovasc Res. 2025 Feb 17:cvaf021. doi: 10.1093.
    >> Share

  11. SHANG R, Rodrigues B
    Cardioprotective effects of a 'twincretin' drug tirzepatide in heart failure following myocardial infarction.
    Cardiovasc Res. 2025 Feb 4:cvaf006. doi: 10.1093.
    >> Share

    January 2025
  12. STEFANSKA K, Sattar N
    Incretin-based weight loss therapies and heart failure with preserved ejection fraction: guideline impactful results, but mechanisms unclear.
    Cardiovasc Res. 2025 Jan 31:cvaf001. doi: 10.1093.
    >> Share

  13. SONI S, Skow RJ, Foulkes S, Haykowsky MJ, et al
    Therapeutic potential of ketone bodies on exercise intolerance in heart failure: looking beyond the heart.
    Cardiovasc Res. 2025 Jan 18:cvaf004. doi: 10.1093.
    >> Share

    December 2024
  14. SCHWARZ KG, Pereyra KV, Diaz-Jara E, Vicencio SC, et al
    Brainstem C1 neurons mediate heart failure decompensation and mortality during acute salt loading.
    Cardiovasc Res. 2024 Dec 30:cvae261. doi: 10.1093.
    >> Share

  15. FUKUMA N, Tokiwa H, Numata G, Ueda K, et al
    Endothelial oestrogen-myocardial cyclic guanosine monophosphate axis critically determines angiogenesis and cardiac performance during pressure overload.
    Cardiovasc Res. 2024;120:1884-1897.
    >> Share

    November 2024
  16. TUBBEN A, Markousis-Mavrogenis G, Meems LMG, van Essen BJ, et al
    Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF.
    Cardiovasc Res. 2024;120:1727-1736.
    >> Share

  17. COROVIC A, Zhao X, Huang Y, Newland SR, et al
    Coronavirus disease 2019-related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities.
    Cardiovasc Res. 2024;120:1752-1767.
    >> Share

  18. ALHASAN KA, King MA, Pattar BSB, Lewis IA, et al
    Anaplerotic filling in heart failure: a review of mechanism and potential therapeutics.
    Cardiovasc Res. 2024 Nov 21:cvae248. doi: 10.1093.
    >> Share

  19. MINISTRINI S, Camici GG
    Inflammation and heart failure: are we facing a "hedgehog's dilemma"?
    Cardiovasc Res. 2024 Nov 16:cvae246. doi: 10.1093.
    >> Share

  20. MONTUORO S, Gentile F, Giannoni A
    Neuroimmune cross-talk in heart failure.
    Cardiovasc Res. 2024 Nov 5:cvae236. doi: 10.1093.
    >> Share

    October 2024
  21. SUN Q, Karwi QG, Wong N, Lopaschuk GD, et al
    Advances in myocardial energy metabolism: metabolic remodeling in heart failure and beyond.
    Cardiovasc Res. 2024 Oct 25:cvae231. doi: 10.1093.
    >> Share

  22. FORTE M, Galli M, Sciarretta S
    Erbb3 and Hspa2, two novel predictors of heart failure in diabetic patients.
    Cardiovasc Res. 2024 Oct 25:cvae220. doi: 10.1093.
    >> Share

  23. NG YH, Koay YC, Marques FZ, Kaye DM, et al
    Leveraging metabolism for better outcomes in heart failure.
    Cardiovasc Res. 2024 Oct 1:cvae216. doi: 10.1093.
    >> Share

    September 2024
  24. HU W, Tu H, Wadman MC, Li YL, et al
    Renal denervation achieves its antiarrhythmic effect through attenuating macrophage activation and neuroinflammation in stellate ganglia in chronic heart failure.
    Cardiovasc Res. 2024 Sep 25:cvae196. doi: 10.1093.
    >> Share

  25. TAKAOKA M, Tadross JA, Al-Hadithi ABAK, Zhao X, et al
    GDF15 antagonism limits severe heart failure and prevents cardiac cachexia.
    Cardiovasc Res. 2024 Sep 23:cvae214. doi: 10.1093.
    >> Share

  26. YANG R, Ruan B, Wang R, Zhang X, et al
    Cardiomyocyte betaII spectrin plays a critical role in maintaining cardiac function by regulating mitochondrial respiratory function.
    Cardiovasc Res. 2024;120:1312-1326.
    >> Share

    August 2024
  27. CONNING-ROWLAND MS, Giannoudi M, Drozd M, Brown OI, et al
    The diabetic myocardial transcriptome reveals Erbb3 and Hspa2 as a novel biomarkers of incident heart failure.
    Cardiovasc Res. 2024 Aug 24:cvae181. doi: 10.1093.
    >> Share

    July 2024
  28. TRUM M, Riechel J, Schollmeier E, Lebek S, et al
    Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF.
    Cardiovasc Res. 2024;120:999-1010.
    >> Share

    June 2024
  29. GRECO CM, Nisoli E
    The ketogenic diet is unable to improve cardiac function in ischemic heart failure: an unexpected result?
    Cardiovasc Res. 2024 Jun 6:cvae126. doi: 10.1093.
    >> Share

    May 2024
  30. FORTE M, Frati G, Sciarretta S
    Phosphodiesterase-mediated modulation of subcellular cAMP levels to reduce heart failure.
    Cardiovasc Res. 2024 May 24:cvae108. doi: 10.1093.
    >> Share

  31. PAVLAKI N, Froese A, Li W, De Jong KA, et al
    Gene therapy with phosphodiesterases 2A and 4B ameliorates heart failure and arrhythmias by improving subcellular cAMP compartmentation.
    Cardiovasc Res. 2024 May 22:cvae094. doi: 10.1093.
    >> Share

  32. HO KL, Karwi Q, Wang F, Wagg C, et al
    The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischemic heart failure.
    Cardiovasc Res. 2024 May 1:cvae092. doi: 10.1093.
    >> Share

    April 2024
  33. KAHNERT K, Soattin L, Mills RW, Wilson C, et al
    Proteomics couples electrical remodelling to inflammation in a murine model of heart failure with sinus node dysfunction.
    Cardiovasc Res. 2024 Apr 25:cvae054. doi: 10.1093.
    >> Share

  34. KASS DA
    Benchmarking pre-clinical heart failure with preserved ejection fraction models: can we do better?
    Cardiovasc Res. 2024 Apr 4:cvae059. doi: 10.1093.
    >> Share

    March 2024
  35. RANGREZ AY, Frey N
    Reverse cardio-oncology: is heart failure-mediated gut dysbiosis the mechanistic driver of colorectal cancer progression?
    Cardiovasc Res. 2024 Mar 28:cvae051. doi: 10.1093.
    >> Share

  36. KESIDOU D, Beqqali A, Baker AH
    The dual effects of miR-222 in cardiac hypertrophy: bridging pathological and physiological paradigms.
    Cardiovasc Res. 2024;120:217-219.
    >> Share

    February 2024
  37. KIZER JR
    The elusive quest for causality in adiponectin's bimodal relationship with cardiovascular disease: Mendelian randomization meets Janus.
    Cardiovasc Res. 2024;120:3-5.
    >> Share

  38. ROLSKI F, Tkacz K, Weglarczyk K, Kwiatkowski G, et al
    TNF-alpha protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells.
    Cardiovasc Res. 2024;120:82-94.
    >> Share

  39. DE WIT S, Geerlings L, Shi C, Dronkers J, et al
    Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice.
    Cardiovasc Res. 2024 Feb 24:cvae038. doi: 10.1093.
    >> Share

  40. GOTTHARDT M, Lehnart SE
    SERCA2a microdomain cAMP changes in heart failure with preserved ejection fraction.
    Cardiovasc Res. 2024 Feb 9:cvae030. doi: 10.1093.
    >> Share

    January 2024
  41. SUN Q, Guven B, Wagg CS, de Oliveira AA, et al
    Mitochondrial fatty acid oxidation is the major source of cardiac ATP production in heart failure with preserved ejection fraction.
    Cardiovasc Res. 2024 Jan 9:cvae006. doi: 10.1093.
    >> Share

  42. ABOULEISA RRE, Tang XL, Ou Q, Salama AM, et al
    Gene therapy encoding cell cycle factors to treat chronic ischemic heart failure in rats.
    Cardiovasc Res. 2024 Jan 4:cvae002. doi: 10.1093.
    >> Share

    December 2023
  43. LAI P, Hille SS, Subramanian H, Weigman R, et al
    Remodelling of cAMP dynamics within the SERCA2a microdomain in heart failure with preserved ejection fraction caused by obesity and type 2 diabetes.
    Cardiovasc Res. 2023 Dec 14:cvad178. doi: 10.1093.
    >> Share

  44. LIU X, Li H, Hastings MH, Xiao C, et al
    miR-222 inhibits pathological cardiac hypertrophyand heart failure.
    Cardiovasc Res. 2023 Dec 12:cvad184. doi: 10.1093.
    >> Share

    November 2023
  45. KATTIH B, Boeckling F, Shumliakivska M, Tombor L, et al
    Single-nuclear transcriptome profiling identifies persistent fibroblast activation in hypertrophic and failing human hearts of patients with longstanding disease.
    Cardiovasc Res. 2023;119:2550-2562.
    >> Share

  46. CICCARELLI M, Pires IF, Bauersachs J, Bertrand L, et al
    Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function.
    Cardiovasc Res. 2023;119:2390-2404.
    >> Share

  47. CORRADI F, Masini G, Bucciarelli T, De Caterina R, et al
    Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives.
    Cardiovasc Res. 2023;119:2405-2420.
    >> Share

  48. WU J, Subbaiah KCV, Hedaya O, Chen S, et al
    FAM210A regulates mitochondrial translation and maintains cardiac mitochondrial homeostasis.
    Cardiovasc Res. 2023;119:2441-2457.
    >> Share

  49. BECHMANN LE, Emanuelsson F, Nordestgaard BG, Benn M, et al
    Genetic variation in solute carrier family 5 member 2 mimicking sodium-glucose co-transporter 2-inhibition and risk of cardiovascular disease and all-cause mortality: reduced risk not explained by lower plasma glucose.
    Cardiovasc Res. 2023;119:2482-2493.
    >> Share

  50. ASHOUR D, Rebs S, Arampatzi P, Saliba AE, et al
    An interferon gamma response signature links myocardial aging and immunosenescence.
    Cardiovasc Res. 2023;119:2458-2468.
    >> Share

    October 2023
  51. NIELSEN MB, Colak Y, Benn M, Mason A, et al
    Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large scale observational and Mendelian randomization evidence.
    Cardiovasc Res. 2023 Oct 28:cvad162. doi: 10.1093.
    >> Share

  52. CUTHBERT JJ, Cleland JGF
    Should we resurrect acetazolamide as a diuretic for congestion due to heart failure?
    Cardiovasc Res. 2023 Oct 18:cvad148. doi: 10.1093.
    >> Share

    September 2023
  53. ZOCCALI C, Mallamaci F, Adamczak M, de Oliveira RB, et al
    Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
    Cardiovasc Res. 2023;119:2017-2032.
    >> Share

    August 2023
  54. CHEN X, Li X, Wu X, Ding Y, et al
    Integrin beta-like 1 mediates fibroblast-cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy.
    Cardiovasc Res. 2023;119:1928-1941.
    >> Share

  55. VISTNES M, Erusappan PM, Sasi A, Norden ES, et al
    Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction.
    Cardiovasc Res. 2023;119:1915-1927.
    >> Share

    July 2023
  56. MARTIN TP, MacDonald EA, Bradley A, Watson H, et al
    RNA interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction.
    Cardiovasc Res. 2023 Jul 11:cvad107. doi: 10.1093.
    >> Share

  57. DA DALT L, Cabodevilla AG, Goldberg IJ, Norata GD, et al
    Cardiac lipid metabolism, mitochondrial function and heart failure.
    Cardiovasc Res. 2023 Jul 1:cvad100. doi: 10.1093.
    >> Share

    June 2023
  58. DAMMAN K, Testani J
    Cardiorenal interactions in heart failure - insights from recent therapeutic advances.
    Cardiovasc Res. 2023 Jun 26:cvad096. doi: 10.1093.
    >> Share

  59. SMART CD, Fehrenbach DJ, Wassenaar JW, Agrawal V, et al
    Immune profiling of murine cardiac leukocytes identifies Trem2 as a novel mediator of hypertensive heart failure.
    Cardiovasc Res. 2023 Jun 14:cvad093. doi: 10.1093.
    >> Share

  60. CHUNG B, Wang Y, Thiel M, Rostami F, et al
    Preemptive iron supplementation prevents myocardial iron deficiency and attenuates adverse remodelling after myocardial infarction.
    Cardiovasc Res. 2023 Jun 14:cvad092. doi: 10.1093.
    >> Share

  61. BASSUK SS, Manson JE
    Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence.
    Cardiovasc Res. 2023;119:1297-1309.
    >> Share

  62. KANY S, Al-Taie C, Roselli C, Pirruccello JP, et al
    Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial.
    Cardiovasc Res. 2023 Jun 2:cvad027. doi: 10.1093.
    >> Share

    May 2023
  63. GROGAN A, Lucero EY, Jiang H, Rockman HA, et al
    Pathophysiology and pharmacology of G protein-coupled receptors in the heart.
    Cardiovasc Res. 2023;119:1117-1129.
    >> Share


  64. Corrigendum to: VEGF-B hypertrophy predisposes to transition from diastolic to systolic heart failure in hypertensive rats.
    Cardiovasc Res. 2023 May 15:cvad073. doi: 10.1093.
    >> Share

  65. DONG M, Chen D, Zhu Y, Yang S, et al
    Impaired regulation of MMP2/16-MLCK3 by miR-146a-5p increased susceptibility to myocardial ischaemic injury in aging mice.
    Cardiovasc Res. 2023;119:786-801.
    >> Share

  66. PHANG RJ, Ritchie RH, Hausenloy DJ, Lees JG, et al
    Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy.
    Cardiovasc Res. 2023;119:668-690.
    >> Share

    March 2023
  67. YANG X, Zhang M, Xie B, Peng Z, et al
    Myocardial brain-derived neurotrophic factor regulates cardiac bioenergetics through the transcription factor Yin Yang 1.
    Cardiovasc Res. 2023;119:571-586.
    >> Share

  68. SAMUELSSON AM, Bartolomaeus TUP, Anandakumar H, Thowsen I, et al
    VEGF-B hypertrophy predisposes to transition from diastolic to systolic heart failure in hypertensive rats.
    Cardiovasc Res. 2023 Mar 23:cvad040. doi: 10.1093.
    >> Share

  69. PARKSOOK WW, Williams GH
    Aldosterone and cardiovascular diseases.
    Cardiovasc Res. 2023;119:28-44.
    >> Share

  70. FAYYAZ AU, Sabbah MS, Dasari S, Griffiths LG, et al
    Histologic and proteomic remodeling of the pulmonary veins and arteries in a porcine model of chronic pulmonary venous hypertension.
    Cardiovasc Res. 2023;119:268-282.
    >> Share

  71. MARKOUSIS-MAVROGENIS G, Minich WB, Al-Mubarak AA, Anker SD, et al
    Clinical and prognostic associations of autoantibodies recognizing adrenergic/muscarinic receptors in patients with heart failure.
    Cardiovasc Res. 2023 Mar 8:cvad042. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016